{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:24Z","timestamp":1788178404541,"version":"build-2803163510"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011919","name":"Federal University of the State of Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008331","name":"Federal University of Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejpb.2026.115191","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:25:32Z","timestamp":1784179532000},"page":"115191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["From the laboratory to the skin: translational potential of nanofibers in the treatment of cutaneous leishmaniasis \u2212 an overview and systematic approach"],"prefix":"10.1016","volume":"227","author":[{"given":"Jo\u00e3o Vitor","family":"Vicente-da-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Querem Nogueira Ferreira","family":"Calheiros-Filha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millena de Sousa","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rika Yoko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio Mendes","family":"Cabral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Ferreira de Carvalho","family":"Patricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Almada","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2022","key":"10.1016\/j.ejpb.2026.115191_b0005","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous leishmaniasis: a updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115191_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1052478","article-title":"Leishmaniasis: recent epidemiological studies in the Middle East","volume":"13","author":"Knight","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2026.115191_b0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40475-021-00232-7","article-title":"A review of leishmaniasis: current knowledge and future directions","volume":"8","author":"Mann","year":"2021","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.ejpb.2026.115191_b0020","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/pathogens14090844","article-title":"Global epidemiology of vector-borne parasitic diseases: burden, trends, disparities, and forecasts (1990-2036)","volume":"14","author":"Wang","year":"2025","journal-title":"Pathogens"},{"key":"10.1016\/j.ejpb.2026.115191_b0025","unstructured":"World Health Organization, Leishmaniasis: Status of endemicity of cutaneous leishmaniasis: 2024, (n.d.). https:\/\/apps.who.int\/neglected_diseases\/ntddata\/leishmaniasis\/leishmaniasis.html (accessed November 5, 2025)."},{"key":"10.1016\/j.ejpb.2026.115191_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2025.107581","article-title":"Local necrosis induced by intralesional treatment with amphotericin B- deoxycholate","volume":"264","author":"Carvalho-Gondim","year":"2025","journal-title":"Acta Tropica"},{"key":"10.1016\/j.ejpb.2026.115191_b0035","unstructured":"World Health Organization, Neglected tropical diseases, (n.d.). https:\/\/www.who.int\/health-topics\/neglected-tropical-diseases#tab=tab_1 (accessed November 5, 2025)."},{"key":"10.1016\/j.ejpb.2026.115191_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011875","article-title":"The changing epidemiology of human leishmaniasis in the non-endemic country of Austria between 2000 to 2021, including a congenital case","volume":"18","author":"Riebenbauer","year":"2024","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107535","article-title":"Comprehensive insights into leishmaniasis: from etiopathogenesis to a novel therapeutic approach","volume":"204","author":"Ansari","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ejpb.2026.115191_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2023.107025","article-title":"Leishmania species infection of bats: a systematic review","volume":"248","author":"de Souza","year":"2023","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejpb.2026.115191_b0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.det.2015.03.018","article-title":"New world and old world leishmania infections: a practical review","volume":"33","author":"Kevric","year":"2015","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ejpb.2026.115191_b0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41572-025-00663-w","article-title":"Leishmaniasis","volume":"11","author":"Pareyn","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejpb.2026.115191_b0065","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2741\/4629","article-title":"Leishmaniasis treatment: update of possibilities for drug repurposing","volume":"23","author":"Andrade-Neto","year":"2018","journal-title":"Front Biosci (landmark Ed)"},{"key":"10.1016\/j.ejpb.2026.115191_b0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/tropicalmed9110258","article-title":"Leishmaniasis in humans and animals: a one-health approach for surveillance, prevention and control in a changing world","volume":"9","author":"Cosma","year":"2024","journal-title":"Trop Med. Infect. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0075","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/tropicalmed7040054","article-title":"Immune responses in Leishmaniasis: an Overview","volume":"7","author":"Costa-da-Silva","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0080","unstructured":"World Health Organization, Leishmaniasis, (2023). https:\/\/www.who.int\/health-topics\/leishmaniasis#tab=tab_1 (accessed November 5, 2025)."},{"key":"10.1016\/j.ejpb.2026.115191_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/idr18010006","article-title":"Beyond the skin: topical amphotericin b nanocarriers targeting cutaneous leishmaniasis with suppression of lymphatic parasite burden","volume":"18","author":"Alexandrino-J\u00fanior","year":"2026","journal-title":"Infectious Disease Reports"},{"key":"10.1016\/j.ejpb.2026.115191_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.microb.2025.100239","article-title":"Leishmaniasis: a multifaceted approach to diagnosis, maladies, drug repurposing and way forward","volume":"6","author":"Makarani","year":"2025","journal-title":"The Microbe"},{"key":"10.1016\/j.ejpb.2026.115191_b0095","first-page":"763","article-title":"Treatment of mucocutaneous leishmaniasis - a systematic review","volume":"22","author":"Fischer","year":"2024","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"10.1016\/j.ejpb.2026.115191_b0100","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1590\/1806-9282.64.03.281","article-title":"Human leishmaniasis in Brazil: a general review","volume":"64","author":"Anversa","year":"2018","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.ejpb.2026.115191_b0105","unstructured":"Pan American Health Organization, Diretrizes para o tratamento das leishmanioses na Regi\u00e3o das Am\u00e9ricas, 2nd ed., 2022. https:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/56487\/9789275725030_por.pdf?sequence=4&isAllowed=y."},{"key":"10.1016\/j.ejpb.2026.115191_b0110","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/microbiolres13040059","article-title":"Cutaneous\/mucocutaneous leishmaniasis treatment for wound healing: classical versus new treatment approaches","volume":"13","author":"Severino","year":"2022","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0115","first-page":"3008","article-title":"Cutaneous and mucocutaneous leishmaniasis: perspectives on immunity","volume":"13","author":"de Souza","year":"2025","journal-title":"Virulence, and Treatment, Biomedicines"},{"key":"10.1016\/j.ejpb.2026.115191_b0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.62310\/liab.v5i2.195","article-title":"Leishmaniasis in humans and small animals: Updates and insights through a one health: leishmaniasis in Humans and Small Animals","volume":"5","author":"Badkoubi","year":"2025","journal-title":"Lett. Animal Biol."},{"key":"10.1016\/j.ejpb.2026.115191_b0125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/pathogens12070969","article-title":"From infection to death: an overview of the pathogenesis of visceral leishmaniasis","volume":"12","author":"Costa","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ejpb.2026.115191_b0130","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejpb.2026.115191_b0135","unstructured":"Pan American Health Organization, Visceral Leishmaniasis, (n.d.). https:\/\/www.paho.org\/en\/topics\/leishmaniasis\/visceral-leishmaniasis (accessed November 5, 2025)."},{"key":"10.1016\/j.ejpb.2026.115191_b0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"Diagnosis and Treatment of Leishmaniasis: Clinical Practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"96","author":"Aronson","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejpb.2026.115191_b0145","unstructured":"Pan American Health Organization, Guideline for the Treatment of Leishmaniasis in the Americas, (2022). 10.37774\/9789275125038."},{"key":"10.1016\/j.ejpb.2026.115191_b0150","unstructured":"Pan American Health Organization, S\u00edntesis de evidencia y recomendaciones: directrices para el tratamiento de las leishmaniasis en la Regi\u00f3n de las Am\u00e9ricas, (2023). 10.26633\/RPSP.2023.43."},{"key":"10.1016\/j.ejpb.2026.115191_b0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/21678707.2024.2335248","article-title":"Current and emerging therapies for the treatment of leishmaniasis","volume":"12","author":"Sundar","year":"2024","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ejpb.2026.115191_b0160","article-title":"Progress in antileishmanial drugs: Mechanisms, challenges, and prospects","volume":"19","author":"Zhang","year":"2025","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0165","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cid\/ciad248","article-title":"Intralesional Antimonial Drug Treatment for Leishmania braziliensis Cutaneous Leishmaniasis: the Knowns and the Unknowns","volume":"77","author":"Aronson","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1590\/0074-02760160183","article-title":"Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre","volume":"111","author":"da Silva","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejpb.2026.115191_b0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s40475-025-00355-1","article-title":"Efficacy and safety in the treatment of patients with cutaneous leishmaniasis of intralesional compared to intramuscular or intravenous administration of meglumine antimony: a systematic review and meta-analysis","volume":"12","author":"Catacora-Zamalloa","year":"2025","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.ejpb.2026.115191_b0180","doi-asserted-by":"crossref","unstructured":"F.B. Cavassin, J.L. Ba\u00fa-Carneiro, R.R. Vilas-Boas, F. Queiroz-Telles, F.B. Cavassin, J.L. Ba\u00fa-Carneiro, R.R. Vilas-Boas, F. Queiroz-Telles, Sixtyyears of AmphotericinB: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections, Infectious Diseases and Therapy 2021 10:1 10 (2021). https:\/\/link.springer.com\/article\/10.1007\/s40121-020-00382-7.","DOI":"10.1007\/s40121-020-00382-7"},{"key":"10.1016\/j.ejpb.2026.115191_b0185","doi-asserted-by":"crossref","DOI":"10.1021\/acsomega.5c05091","article-title":"Enhanced Skin delivery of amphotericin B: development and evaluation of polymeric nanoparticles using a porcine ear model","author":"Maciel-Magalh\u00e3es","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2026.115191_b0190","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3390\/pharmaceutics14122707","article-title":"Could the lung be a gateway for amphotericin B to attack the army of fungi?","volume":"14","author":"de Carvalho Patricio","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115191_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2025.106880","article-title":"Continuous-flow microfluidic process to produce amphotericin B-loaded polymeric nanoparticles for cutaneous leishmaniasis treatment","volume":"108","author":"Nader-Mota","year":"2025","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115191_b0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1051\/parasite\/2025009","article-title":"Leishmaniases: strategies in treatment development","volume":"32","author":"Majoor","year":"2025","journal-title":"Parasite"},{"key":"10.1016\/j.ejpb.2026.115191_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2020.101664","article-title":"A review of current treatments strategies based on paromomycin for leishmaniasis","volume":"57","author":"Matos","year":"2020","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115191_b0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jaad.2009.06.088","article-title":"New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment","volume":"63","author":"Mitropoulos","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115191_b0215","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115191_b0220","unstructured":"Brasil, Manual de Vigil\u00e2ncia da Leishmaniose Tegumentar, (2017). https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_vigilancia_leishmaniose_tegumentar.pdf."},{"key":"10.1016\/j.ejpb.2026.115191_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293529","article-title":"Treatment outcomes of cutaneous leishmaniasis due to Leishmania aethiopica: a systematic review and meta-analysis","volume":"18","author":"Alemu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2026.115191_b0230","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.18295\/2075-0528.2931","article-title":"The Efficacy of Topical Paromomycin-Gentamicin versus Topical Paromomycin Alone in the Treatment of Cutaneous Leishmaniasis: a meta-analysis of randomized controlled trials","volume":"25","author":"Alshaikh","year":"2025","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.ejpb.2026.115191_b0235","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10822-019-00230-y","article-title":"Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations","volume":"33","author":"Bustamante","year":"2019","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejpb.2026.115191_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1573618","article-title":"Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapies","volume":"12","author":"Bhusal","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejpb.2026.115191_b0245","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2026.115191_b0250","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management","volume":"3","author":"Sundar","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ejpb.2026.115191_b0255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182017000993","article-title":"Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art","volume":"145","author":"Charlton","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejpb.2026.115191_b0260","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40249-018-0444-1","article-title":"Innovation in neglected tropical disease drug discovery and development","volume":"7","author":"Weng","year":"2018","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.ejpb.2026.115191_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2024.1460100","article-title":"How drug repurposing can advance drug discovery: challenges and opportunities","volume":"4","author":"Pinzi","year":"2024","journal-title":"Front. Drug Discov."},{"key":"10.1016\/j.ejpb.2026.115191_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1403589","article-title":"Approved drugs successfully repurposed against Leishmania based on machine learning predictions","volume":"14","author":"Oualha","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejpb.2026.115191_b0275","first-page":"1117","article-title":"In silico approaches supporting drug repurposing for Leishmaniasis: a scoping review","volume":"23","author":"Scheiffer","year":"2024","journal-title":"EXCLI J."},{"key":"10.1016\/j.ejpb.2026.115191_b0280","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12982-024-00247-1","article-title":"Classical and innovative drugs for the treatment of Leishmania infections","volume":"21","author":"Mota","year":"2024","journal-title":"Discov. Public Health"},{"key":"10.1016\/j.ejpb.2026.115191_b0285","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/acs.molpharmaceut.0c00154","article-title":"Nanodelivery systems for topical management of skin disorders","volume":"18","author":"Cui","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115191_b0290","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s13346-022-01262-y","article-title":"Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes","volume":"13","author":"Dri","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0295","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.2147\/DDDT.S447496","article-title":"Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs","volume":"18","author":"Liu","year":"2024","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejpb.2026.115191_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11050200","article-title":"A functional wound dressing as a potential treatment for cutaneous leishmaniasis","volume":"11","author":"Alexandrino-Junior","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115191_b0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/pharmaceutics15010099","article-title":"Liposomal amphotericin B for treatment of leishmaniasis: from the identification of critical physicochemical attributes to the design of effective topical and oral formulations","volume":"15","author":"Fr\u00e9zard","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115191_b0320","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00631-18","article-title":"Local skin inflammation in cutaneous leishmaniasis as a source of variable pharmacokinetics and therapeutic efficacy of liposomal amphotericin B","volume":"62","author":"Wijnant","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejpb.2026.115191_b0325","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0330","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-020-00740-5","article-title":"Challenges in nanomedicine clinical translation","volume":"10","author":"Metselaar","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0335","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0340","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.5c00586","article-title":"Advances in transdermal drug delivery systems for antithrombotic therapy: a systematic review","author":"Stersi","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics7040438","article-title":"Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum","volume":"7","author":"Alkilani","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115191_b0350","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijpara.2007.04.007","article-title":"The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist","volume":"37","author":"Kima","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejpb.2026.115191_b0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009099","article-title":"Therapeutic advances in the topical treatment of cutaneous leishmaniasis: a review","volume":"15","author":"Azim","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0360","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00436-025-08605-x","article-title":"Nanofibrous patches for targeted therapy of cutaneous leishmaniasis caused by Leishmania major: a preclinical amphotericin B platform","volume":"124","author":"Allahmoradi","year":"2025","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0365","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.220058","article-title":"Nanomedicine-based strategies to improve treatment of cutaneous leishmaniasis","volume":"9","author":"Goonoo","year":"2022","journal-title":"R. Soc. Open Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0370","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10856-022-06700-4","article-title":"Polymeric nanofibers for drug delivery applications: a recent review","volume":"33","author":"Duan","year":"2022","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ejpb.2026.115191_b0375","article-title":"A review on fabrication methods of nanofibers and a special focus on application of cellulose nanofibers","volume":"4","author":"Anusiya","year":"2022","journal-title":"Carbohydr. Polym. Technol. Appl."},{"key":"10.1016\/j.ejpb.2026.115191_b0380","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/pr12102100","article-title":"Challenges associated with the production of nanofibers","volume":"12","author":"Maduna","year":"2024","journal-title":"Processes"},{"key":"10.1016\/j.ejpb.2026.115191_b0385","series-title":"21st Century Nanostructured Materials - Physics, Chemistry, Classification, and Emerging Applications in Industry, Biomedicine, and Agriculture","article-title":"Nanofibers: Production, Characterization, and Tissue Engineering Applications","author":"Bayrak","year":"2022"},{"key":"10.1016\/j.ejpb.2026.115191_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18917","article-title":"Nanofibers: a current era in drug delivery system","volume":"9","author":"Hiwrale","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ejpb.2026.115191_b0405","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1039\/D2RA06023J","article-title":"Electrospun nanofibres in drug delivery: advances in controlled release strategies","volume":"13","author":"Gaydhane","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2026.115191_b0410","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.3390\/molecules29174271","article-title":"Advances in electrospun nanofiber membranes for dermatological applications: a review","volume":"29","author":"Han","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115191_b0415","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s13346-022-01250-2","article-title":"Preparation, optimization, and in vitro-in vivo evaluation of sorafenib-loaded polycaprolactone and cellulose acetate nanofibers for the treatment of cutaneous leishmaniasis","volume":"13","author":"Alemomen","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0420","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ijbiomac.2020.06.240","article-title":"Glucantime-loaded electrospun core-shell nanofibers composed of poly(ethylene oxide)\/gelatin-poly(vinyl alcohol)\/chitosan as dressing for cutaneous leishmaniasis","volume":"163","author":"Alishahi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2026.115191_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120911","article-title":"Fabrication of amphotericin B-loaded electrospun core-shell nanofibers as a novel dressing for superficial mycoses and cutaneous leishmaniasis","volume":"606","author":"Asgari","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115191_b0430","doi-asserted-by":"crossref","DOI":"10.1002\/pat.6460","article-title":"Clinical assessment of novel nanofibrous dressings for cutaneous leishmaniasis: a trial-based study","volume":"35","author":"Bagheri","year":"2024","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.ejpb.2026.115191_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.jscs.2021.101362","article-title":"Therapeutic effects of the as-synthesized polylactic acid\/chitosan nanofibers decorated with amphotricin B for in vitro treatment of Leishmaniasis","volume":"25","author":"Bahraminegad","year":"2021","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.ejpb.2026.115191_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111390","article-title":"Polyvinyl alcohol-based electrospun matrix as a delivery system for nanoemulsion containing chalcone against Leishmania (Leishmania) amazonensis","volume":"198","author":"Coelho","year":"2021","journal-title":"Colloid Surf. B-Biointerfaces"},{"key":"10.1016\/j.ejpb.2026.115191_b0445","first-page":"11066","article-title":"Impregnated nanofibrous mat with nanogel of citrus sinensis essential oil as a new type of dressing in cutaneous leishmaniasis","volume":"11","author":"Ghanbariasad","year":"2021","journal-title":"Biointerface Res. Appl. Chem."},{"key":"10.1016\/j.ejpb.2026.115191_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.molbiopara.2024.111663","article-title":"Glucantime and quercetin electrospun nanofiber membranes: Fabrication and their evaluation as dressing for cutaneous leishmaniasis","volume":"261","author":"Karamian","year":"2025","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ejpb.2026.115191_b0455","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2010.09-0287","article-title":"Dar\u00edo V\u00e9lez, a controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis","volume":"83","author":"L\u00f3pez-Jaramillo","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejpb.2026.115191_b0460","doi-asserted-by":"crossref","DOI":"10.18502\/jad.v17i4.15294","article-title":"Anti-leishmanial effects of a novel biocompatible non-invasive nanofibers containing royal jelly and propolis against iranian strain of leishmania major (MRHO\/IR\/75\/ER): an in-vitro study","author":"Mahmoudi","year":"2024","journal-title":"JAD"},{"key":"10.1016\/j.ejpb.2026.115191_b0465","first-page":"286","article-title":"Anti-leishmanial effects of chitosan-polyethylene oxide nanofibers containing berberine: an applied model for leishmania wound dressing","volume":"45","author":"Rahimi","year":"2020","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0470","first-page":"788","article-title":"Chitosan-based nano-scaffolds as antileishmanial wound dressing in BALB\/c mice treatment: Characterization and design of tissue regeneration","volume":"23","author":"Tabaei","year":"2020","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0475","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jfb17010041","article-title":"Tri-layer composite nanofiber wound dressing incorporating glucantime and silver nanoparticles for cutaneous leishmaniasis management","volume":"17","author":"Topuz","year":"2026","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.ejpb.2026.115191_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.123173","article-title":"Solution blow spun polymeric nanofibres embedding cyclodextrin complexes of miltefosine: an approach to the production of sprayable dressings for the treatment of cutaneous leishmaniasis","volume":"353","author":"Dirany","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2026.115191_b0485","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.571821","article-title":"Effectiveness of core-shell nanofibers incorporating amphotericin B by solution blow spinning against leishmania and candida species","volume":"8","author":"Goncalves","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115191_b0490","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/polym18020170","article-title":"Pentamidine-functionalized polycaprolactone nanofibers produced by solution blow spinning for controlled release in cutaneous leishmaniasis treatment","volume":"18","author":"Guembe-Michel","year":"2026","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2026.115191_b0495","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/polym15010065","article-title":"Electrospun polymer nanofibers: processing properties, and applications","volume":"15","author":"Al-Abduljabbar","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2026.115191_b0500","doi-asserted-by":"crossref","DOI":"10.1002\/adem.202301297","article-title":"An overview of the electrospinning of polymeric nanofibers for biomedical applications related to drug delivery","volume":"26","author":"CeCe","year":"2024","journal-title":"Adv. Eng. Mater."},{"key":"10.1016\/j.ejpb.2026.115191_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.lddd.2026.100291","article-title":"Polymeric nanofibers: Quality by design: perspectives and prospects","volume":"22","author":"Maji","year":"2025","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.ejpb.2026.115191_b0510","doi-asserted-by":"crossref","first-page":"18340","DOI":"10.1021\/acsomega.3c00924","article-title":"Evolving trends in nanofibers for topical delivery of therapeutics in skin disorders","volume":"8","author":"Tomar","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2026.115191_b0515","series-title":"Natural and Synthetic Biomedical Polymers","first-page":"387","article-title":"Polymeric Biomaterials in Nanomedicine","author":"Banik","year":"2014"},{"key":"10.1016\/j.ejpb.2026.115191_b0520","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2016.06.018","article-title":"Polylactic acid (PLA) controlled delivery carriers for biomedical applications","volume":"107","author":"Tyler","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115191_b0525","article-title":"Polyvinyl alcohol-based separation membranes: a comprehensive review on fabrication techniques, applications and future prospective","volume":"28","author":"Vatanpour","year":"2023","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.ejpb.2026.115191_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2025.114033","article-title":"Polycaprolactone (PCL): the biodegradable polyester shaping the future of materials \u2013 a review on synthesis, properties, biodegradation, applications and future perspectives","volume":"234","author":"Ntrivala","year":"2025","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.ejpb.2026.115191_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.111512","article-title":"Medical applications and prospects of polylactic acid materials","volume":"27","author":"Yang","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.ejpb.2026.115191_b0540","series-title":"Natural and Synthetic Biomedical Polymers","first-page":"1","article-title":"Polymer synthesis and processing","author":"Kariduraganavar","year":"2014"},{"key":"10.1016\/j.ejpb.2026.115191_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2025.114161","article-title":"Synergistic approaches in natural and synthetic polymer blends for biomedical applications-a review","volume":"236","author":"Suhas","year":"2025","journal-title":"Eur. Poly. J."},{"key":"10.1016\/j.ejpb.2026.115191_b0550","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.progpolymsci.2011.05.003","article-title":"Current research on the blends of natural and synthetic polymers as new biomaterials: review","volume":"36","author":"Sionkowska","year":"2011","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0555","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/pharmaceutics11070305","article-title":"Drug delivery applications of core-sheath nanofibers prepared by coaxial electrospinning: a review","volume":"11","author":"Pant","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115191_b0560","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1021\/acssuschemeng.7b00863","article-title":"Electrospinning biopolymers from ionic liquids requires control of different solution properties than volatile organic solvents","volume":"5","author":"Zavgorodnya","year":"2017","journal-title":"ACS Sustainable Chem. Eng."},{"key":"10.1016\/j.ejpb.2026.115191_b0565","doi-asserted-by":"crossref","first-page":"25712","DOI":"10.1039\/C9RA05012D","article-title":"Electrospun fibers and their application in drug controlled release, biological dressings, tissue repair, and enzyme immobilization","volume":"9","author":"Sun","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejpb.2026.115191_b0570","series-title":"Electrospinning - Material, Techniques, and Biomedical Applications","article-title":"Dependent and independent parameters of needleless electrospinning","author":"Yalcinkaya","year":"2016"},{"key":"10.1016\/j.ejpb.2026.115191_b0575","article-title":"Electrospinning and nanofiber technology: fundamentals innovations, and applications","volume":"37","author":"Cho","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2026.115191_b0580","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0266-3538(03)00178-7","article-title":"A review on polymer nanofibers by electrospinning and their applications in nanocomposites","volume":"63","author":"Huang","year":"2003","journal-title":"Compos. Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115191_b0585","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1533367","article-title":"Electrospun nanofibers and their application as sensors for healthcare","volume":"13","author":"Zhao","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115191_b0590","doi-asserted-by":"crossref","DOI":"10.3390\/foods13132114","article-title":"Development of hybrid electrospun nanofibers: improving effects of cellulose nanofibers (CNFs) on electrospinnability of gelatin","volume":"13","author":"Hajieghrary","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.ejpb.2026.115191_b0595","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1021\/acs.chemrev.8b00593","article-title":"Electrospinning and electrospun nanofibers: methods, materials, and applications","volume":"119","author":"Xue","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejpb.2026.115191_b0600","article-title":"Application of green solvents as a replacement of toxic dimethylformamide in the polylactic acid electrospinning process","volume":"44","author":"Loveck\u00e1","year":"2025","journal-title":"Sustain. Mater. Technol."},{"key":"10.1016\/j.ejpb.2026.115191_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.105156","article-title":"Electrospun nanofibers: exploring process parameters, polymer selection, and recent applications in pharmaceuticals and drug delivery","volume":"90","author":"Abdulhussain","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115191_b0615","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.biotechadv.2010.01.004","article-title":"Electrospinning: a fascinating fiber fabrication technique","volume":"28","author":"Bhardwaj","year":"2010","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejpb.2026.115191_b0620","doi-asserted-by":"crossref","DOI":"10.3390\/polym15010065","article-title":"Electrospun polymer nanofibers: processing, properties, and applications","volume":"15","author":"Al-Abduljabbar","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2026.115191_b0625","article-title":"Effect of electrospinning parameters on the fiber diameter and morphology of PLGA nanofibers","volume":"4","author":"Kalluri","year":"2021","journal-title":"Dent. Oral. Biol. Craniofacial. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0630","doi-asserted-by":"crossref","DOI":"10.3390\/en18092399","article-title":"Advancing electrochemical energy storage: a review of electrospinning factors and their impact","volume":"18","author":"Kashif","year":"2025","journal-title":"Energies"},{"key":"10.1016\/j.ejpb.2026.115191_b0635","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/ijms25031668","article-title":"PVA-based electrospun materials\u2014a promising route to designing nanofiber mats with desired morphological shape\u2014a review","volume":"25","author":"T\u00fcrko\u011flu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0640","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1039\/D0MH01096K","article-title":"Recent progress and challenges in solution blow spinning","volume":"8","author":"Gao","year":"2021","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.ejpb.2026.115191_b0645","doi-asserted-by":"crossref","first-page":"34951","DOI":"10.1021\/acsami.6b12994","article-title":"A review of the fundamental principles and applications of solution blow spinning","volume":"8","author":"Daristotle","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ejpb.2026.115191_b0650","article-title":"Solution blow spinning (SBS) and SBS-spun nanofibers: materials, methods, and applications","volume":"25","author":"Dadol","year":"2020","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.ejpb.2026.115191_b0655","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.3390\/ijms241914757","article-title":"Advances in biomedical applications of solution blow spinning","volume":"24","author":"Carriles","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0660","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/app.30275","article-title":"Solution blow spinning: a new method to produce micro- and nanofibers from polymer solutions","volume":"113","author":"Medeiros","year":"2009","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0665","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1016\/j.ceramint.2014.06.104","article-title":"Fabrication of ZrO2 ceramic fiber mats by solution blowing process","volume":"40","author":"Cheng","year":"2014","journal-title":"Ceram. Int."},{"key":"10.1016\/j.ejpb.2026.115191_b0670","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1021\/ie4037142","article-title":"Numerical study on the solution blowing annular jet and its correlation with fiber morphology","volume":"53","author":"Lou","year":"2014","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0675","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1002\/app.30938","article-title":"Generation of polymer ultrafine fibers through solution (air-) blowing","volume":"114","author":"Zhang","year":"2009","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0680","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/app.39317","article-title":"Systematic investigation on parameters of solution blown micro\/nanofibers using response surface methodology based on box-Behnken design","volume":"130","author":"Lou","year":"2013","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.ejpb.2026.115191_b0685","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/jbm.b.34238","article-title":"Comparative study of aligned and nonaligned poly(\u03b5-caprolactone) fibrous scaffolds prepared by solution blow spinning","volume":"107","author":"Simbara","year":"2019","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.ejpb.2026.115191_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.medntd.2025.100386","article-title":"Engineering nanofibers for cutaneous drug delivery systems and therapeutic applications","volume":"27","author":"Pradhan","year":"2025","journal-title":"Med. Novel Technol. Devices"},{"key":"10.1016\/j.ejpb.2026.115191_b0695","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2026.115191_b0700","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2217\/nnm-2017-0017","article-title":"Recent advances in electrospun nanofibers for wound healing","volume":"12","author":"Chen","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115191_b0705","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actbio.2020.03.035","article-title":"Mesenchymal stem cell-laden, personalized 3D scaffolds with controlled structure and fiber alignment promote diabetic wound healing","volume":"108","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2026.115191_b0710","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.3390\/ma13102407","article-title":"Nanostructured fibers containing natural or synthetic bioactive compounds in wound dressing applications","volume":"13","author":"Croitoru","year":"2020","journal-title":"Materials"},{"key":"10.1016\/j.ejpb.2026.115191_b0715","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1039\/D1TB00067E","article-title":"Electrospun nanofibers promote wound healing: theories, techniques, and perspectives","volume":"9","author":"Gao","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejpb.2026.115191_b0720","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1021\/acsomega.5c00455","article-title":"Skin and wound healing: conventional dosage versus nanobased emulsions forms","volume":"10","author":"Vicente-da-Silva","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2026.115191_b0725","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/pharmaceutics15071829","article-title":"Nanofiber scaffolds as drug delivery systems promoting wound healing","volume":"15","author":"Jiang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115191_b0730","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pim.12007","article-title":"Tissue damage and immunity in cutaneous leishmaniasis","volume":"34","author":"Nyl\u00e9n","year":"2012","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ejpb.2026.115191_b0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.colcom.2022.100620","article-title":"Dual functional electrospun nanofiber membrane with ROS scavenging and revascularization ability for diabetic wound healing","volume":"48","author":"Sheng","year":"2022","journal-title":"Colloid Interface Sci. Commun."},{"key":"10.1016\/j.ejpb.2026.115191_b0740","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/pathogens12020246","article-title":"Unrevealing the mystery of latent leishmaniasis: what cells can host leishmania?","volume":"12","author":"Valigurov\u00e1","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ejpb.2026.115191_b0745","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060945","article-title":"Fibroblasts\u2014warriors at the intersection of wound healing and disrepair","volume":"13","author":"Roman","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejpb.2026.115191_b0750","doi-asserted-by":"crossref","DOI":"10.3390\/life15111748","article-title":"Molecular mechanisms of wound healing: the role of medicinal plants","volume":"15","author":"Esad","year":"2025","journal-title":"Life"},{"key":"10.1016\/j.ejpb.2026.115191_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2023.100158","article-title":"Nanomaterials for diagnosis, treatment, and prevention of human cutaneous leishmaniasis: a review","volume":"12","author":"Maza Vega","year":"2023","journal-title":"OpenNano"},{"key":"10.1016\/j.ejpb.2026.115191_b0760","first-page":"356","article-title":"Prevalence of cutaneous Leishmaniasis in the Middle East: a systematic review and meta-analysis, Pathog Glob","volume":"117","author":"Karami","year":"2023","journal-title":"Health"},{"key":"10.1016\/j.ejpb.2026.115191_b0765","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1590\/s1678-9946202567023","article-title":"Spatial epidemiologic trends of cutaneous leishmaniasis in Rio de Janeiro State, Southeast Brazil, 2001\u20132020","volume":"67","author":"de S\u00e1","year":"2025","journal-title":"Rev. Inst. Med. Trop. S. Paulo"},{"key":"10.1016\/j.ejpb.2026.115191_b0770","article-title":"Cutaneous leishmaniasis treatment and therapeutic outcomes in special populations: a collaborative retrospective study","volume":"17","author":"del M Castro","year":"2023","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2025.107863","article-title":"Spatiotemporal epidemiology of cutaneous, mucosal, and visceral leishmaniasis in Colombia, 1980\u20132025: insights from a 45-year national analysis","volume":"271","author":"Olivera","year":"2025","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejpb.2026.115191_b0780","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jamadermatol.2018.2133","article-title":"Incidence of endemic human cutaneous leishmaniasis in the United States","volume":"154","author":"McIlwee","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ejpb.2026.115191_b0785","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amsu.2017.12.014","article-title":"A decade bibliometric analysis of global research on leishmaniasis in Web of Science database","volume":"26","author":"Soosaraei","year":"2018","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ejpb.2026.115191_b0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006697","article-title":"Burden of leishmaniasis in Brazil and federated units, 1990-2016: findings from global burden of disease study 2016","volume":"12","author":"Bezerra","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0795","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011134","article-title":"Evolution of research funding for neglected tropical diseases in Brazil, 2004\u20132020","volume":"17","author":"Melo","year":"2023","journal-title":"PLOS Neglected Tropical Diseases"},{"key":"10.1016\/j.ejpb.2026.115191_b0800","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40249-023-01103-1","article-title":"High-risk spatiotemporal patterns of cutaneous leishmaniasis: a nationwide study in Iran from 2011 to 2020","volume":"12","author":"Firouraghi","year":"2023","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.ejpb.2026.115191_b0805","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13071-021-04619-3","article-title":"A long-lasting emerging epidemic of anthroponotic cutaneous leishmaniasis in southeastern Iran: population movement and peri-urban settlements as a major risk factor","volume":"14","author":"Karimi","year":"2021","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.ejpb.2026.115191_b0810","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1091709","article-title":"Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan","volume":"11","author":"Sharifi","year":"2023","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ejpb.2026.115191_b0815","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1574891X10666150410165445","article-title":"Study of the scientific production on leishmaniasis in latin america","volume":"9","author":"Perilla-Gonzalez","year":"2013","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"key":"10.1016\/j.ejpb.2026.115191_b0820","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25235704","article-title":"Colombian contributions fighting leishmaniasis: a systematic review on antileishmanials combined with chemoinformatics analysis","volume":"25","author":"S\u00e1nchez-Su\u00e1rez","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115191_b0825","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13112485","article-title":"Autochthonous leishmaniasis in the United States of America","volume":"13","author":"Yao","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejpb.2026.115191_b0830","doi-asserted-by":"crossref","DOI":"10.2196\/65579","article-title":"rising leishmaniasis cases in the united states based on registry data from 2007 to 2023 and the vital role of health care providers in awareness and management","volume":"8","author":"Panlilio","year":"2025","journal-title":"JMIR Dermatology"},{"key":"10.1016\/j.ejpb.2026.115191_b0835","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9030578","article-title":"Leishmaniasis in the united states: emerging issues in a region of low endemicity","volume":"9","author":"Curtin","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.ejpb.2026.115191_b0840","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/tmi.13478","article-title":"Neglected tropical diseases in Brazil: lack of correlation between disease burden, research funding and output","volume":"25","author":"Fonseca","year":"2020","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejpb.2026.115191_b0845","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10030356","article-title":"Publication trends in neglected tropical diseases of latin america and the caribbean: a bibliometric analysis","volume":"10","author":"Fontecha","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.ejpb.2026.115191_b0850","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijpddr.2018.09.006","article-title":"Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis","volume":"8","author":"Alc\u00e2ntara","year":"2018","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejpb.2026.115191_b0855","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s41182-026-00951-5","article-title":"The pharmaceutical industry\u2019s multifaceted role in neglected tropical disease control: from market failure to global health innovation","volume":"54","author":"Sanchez","year":"2026","journal-title":"Trop. Med. Health"},{"key":"10.1016\/j.ejpb.2026.115191_b0860","unstructured":"J.H. Collier, Y. Wu, V.P. Conticello, Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform, US 11246924 B2, 2022. https:\/\/www.lens.org\/lens\/patent\/188-159-475-023-875\/frontpage (accessed February 15, 2026)."},{"key":"10.1016\/j.ejpb.2026.115191_b0865","unstructured":"C. Fries, G. Fouda, J.H. Collier, Nanofibers to prime antibody responses and methods of using same, US 2025\/0276058 A1, 2025. https:\/\/www.lens.org\/lens\/patent\/021-218-731-779-454\/frontpage?l=en (accessed February 15, 2026)."},{"key":"10.1016\/j.ejpb.2026.115191_b0870","unstructured":"J.H. Collier, E. Curvino, Compositions and methods for anti-phosphocholine active immunotherapy, US 2025\/0281629 A1, 2025. https:\/\/www.lens.org\/lens\/patent\/069-406-134-521-615\/frontpage?l=en (accessed February 15, 2026)."},{"key":"10.1016\/j.ejpb.2026.115191_b0875","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.biotechadv.2017.05.002","article-title":"Harnessing self-assembled peptide nanoparticles in epitope vaccine design","volume":"35","author":"Negahdaripour","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ejpb.2026.115191_b0880","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1021\/acs.biomac.5b00572","article-title":"A self-assembling peptide scaffold for the multivalent presentation of antigens","volume":"16","author":"Zacco","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2026.115191_b0885","doi-asserted-by":"crossref","first-page":"26799","DOI":"10.1021\/acsnano.4c07602","article-title":"Scalable self-assembly of composite nanofibers into high-energy-density li-ion battery electrodes","volume":"18","author":"Wang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.115191_b0890","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mattod.2019.04.018","article-title":"Scalable manufacturing and applications of nanofibers","volume":"28","author":"Huang","year":"2019","journal-title":"Mater. Today"},{"key":"10.1016\/j.ejpb.2026.115191_b0895","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0900","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1544393","article-title":"Regulatory pathways and guidelines for nanotechnology-enabled health products: a comparative review of EU and US frameworks","volume":"12","author":"Rodr\u00edguez-G\u00f3mez","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.ejpb.2026.115191_b0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.126172","article-title":"Vitamin B12-PEG4000 functionalized cellulose nanofibers for Amphotericin B delivery: In vitro evaluation for leishmaniasis treatment","volume":"684","author":"Chatap","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115191_b0910","article-title":"Gelatin nanofiber assisted zero order release of amphotericin-B: a study with realistic drug loading for oral formulation","volume":"24","author":"Gaydhane","year":"2020","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.ejpb.2026.115191_b0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.nanoso.2019.100367","article-title":"Compressed nanofibrous oral tablets: an ingenious way for controlled release kinetics of Amphotericin-B loaded gelatin nanofibers","volume":"19","author":"Laha","year":"2019","journal-title":"Nano-Struct. Nano-Objects"},{"key":"10.1016\/j.ejpb.2026.115191_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.105235","article-title":"An overview of nanofibers and microfibers for improved oral delivery of medicines: challenges and advances","volume":"91","author":"Ghasemiyeh","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115191_b0925","doi-asserted-by":"crossref","first-page":"e1859","DOI":"10.1002\/wnan.1859","article-title":"Optimal delivery of poorly soluble drugs using electrospun nanofiber technology: challenges, state of the art, and future directions","volume":"15","author":"Pattnaik","year":"2023","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.ejpb.2026.115191_b0930","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1021\/acs.molpharmaceut.9b00798","article-title":"Fast dissolving oral drug delivery system based on electrospun nanofibrous webs of cyclodextrin\/ibuprofen inclusion complex nanofibers","volume":"16","author":"Celebioglu","year":"2019","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115191_b0935","article-title":"Design and preparation of novel domperidone loaded polymeric blend electrospun nanofibers for improved oral pharmacodynamic activity","author":"Shatla","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115191_b0940","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16040449","article-title":"Recent approaches for the topical treatment of psoriasis using nanoparticles","volume":"16","author":"Bodn\u00e1r","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115191_b0945","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009734","article-title":"An old drug and different ways to treat cutaneous leishmaniasis: intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil","volume":"15","author":"Oliveira-Ribeiro","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2026.115191_b0950","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm87030019","article-title":"Methods to evaluate skin penetration in vitro","volume":"87","author":"Zsik\u00f3","year":"2019","journal-title":"Sci. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:13:35Z","timestamp":1788174815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":185,"alternative-id":["S0939641126002122"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115191","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From the laboratory to the skin: translational potential of nanofibers in the treatment of cutaneous leishmaniasis \u2212 an overview and systematic approach","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115191"}}